Location History:
- Auckland, NZ (2005)
- Hong Kong, KH (2011)
- Hong Kong, CN (2008 - 2013)
Company Filing History:
2 out of 8 
2 out of 334 
1 out of 14 Years Active: 2005-2013
Title: Aimin Xu: Innovator in Metabolic Disorder Treatments
Introduction
Aimin Xu is a prominent inventor based in Hong Kong, CN, known for his significant contributions to the field of metabolic disorders. With a total of 5 patents, he has focused on developing innovative methods and compositions for treating obesity and related metabolic conditions.
Latest Patents
Among his latest patents, Aimin Xu has developed Lipocalin-2 antibodies for methods of treatment. This invention provides methods and compositions for identifying and treating obesity and obesity-induced metabolic disorders. One aspect of his work includes a method for evaluating the risk and progression of glucose tolerance, insulin resistance, and Type 2 diabetes in mammalian subjects. This method involves measuring the concentration of circulating lipocalin-2 in a subject and comparing the measured level to a reference level. Additionally, he has created methods for treating insulin resistance, Type 2 diabetes, and other related complications by administering a composition that can reduce circulating levels of lipocalin-2, such as a lipocalin-2 antagonist. Another notable patent involves adiponectin and its uses, providing methods and reagents for regulating metabolic events mediated by adiponectin and adiponectin agonists.
Career Highlights
Aimin Xu has worked with notable organizations, including Protemix Corporation Limited and The University of Hong Kong. His work in these institutions has allowed him to advance his research and contribute to the scientific community significantly.
Collaborations
Throughout his career, Aimin Xu has collaborated with esteemed colleagues, including Yu Wang and Garth Cooper. These collaborations have further enriched his research and innovation in the field.
Conclusion
Aimin Xu's innovative work in the treatment of metabolic disorders showcases his dedication to advancing medical science. His patents reflect a commitment to improving health outcomes for individuals affected by obesity and related conditions.